Drug Trial Radar · NCT00547378
InSite for Over Active Bladder
Last checked: Nov 20, 2026Latest source record: Dec 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
571
Actual
Start
Oct 2007
Primary completion
Aug 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- MedtronicNeuroIndustry
- Sponsor type
- Industry
- First posted
- Oct 22, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purposes of this study are: 1. To provide evidence from a randomized controlled trial that InterStim Therapy provides better relief of symptoms of OAB than standard medical treatments in current use. 2. To fulfill the requirements of the FDA-mandated post-approval study of the safety of the tined lead using a minimally invasive approach.
Conditions
- Urinary Incontinence, Urgency-frequency
- Overactive Bladder
Interventions
InterStimDevice
Standard Medical TherapyDrug
Oxybutynin 2.5mg, 5mg Oxybutynin extended release 5 mg, 10mg, 15mg Oxybutynin transdermal 3.9mg Solifenacin 5mg, 10mg Tolterodine 1mg, 2mg Tolterodine extended release 2mg, 4mg Trospium 20mg Darifenacin extended release 7.5mg, 15mg fesoterodine Fumarate 4mg, 8mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Randomized Cohort: OAB Therapeutic ResponseTime frame: 6 months
- All Implanted Cohort: Adverse Events Related to the Tined Lead That Require SurgeryTime frame: 5 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.